European Respiratory Journal: Immunosuppressive macrophages contribute to the disease progression of LAM https://bit.ly/43YosJa

ERJ Open Research: It seems advisable to systematically detect and correct patient–ventilator interactions in home mechanical ventilated patients https://bit.ly/4hTsyq3

Learn more about recent scientific developments in pneumonia this #WorldPneumoniaDay with our ERS Publications collection 🦠 Access information on community-acquired pneumonia, drug-resistance, and more: https://bit.ly/49wuAvN

Defend and trust in science. Protect public health. That is our message to European Union leaders. Watch as Joanna Chorostowska-Wynimko, ERS President, explains 💬

Eur Respir J: The impairment of IgA-related mucosal immunity after lung transplantation occurs early in the development of bronchiolitis obliterans syndrome (BOS), preceding clinical diagnosis. This suggests its potential as a predictor for BOS onset. https://bit.ly/3RVMmyp

ERJ Open Research: ETI therapy in patients with NCFB and an amenable CFTR mutation led to a significant improvement in pulmonary function, clinical status and daily symptoms, suggesting ETI may prove beneficial as an adjuvant therapy for NCFB https://bit.ly/3DVXiIQ

📖 The forthcoming ERS Monograph on “Chronic Cough” is now available to pre-order. The book will cover pathophysiology, assessment, management, treatable traits & future directions. Pre-order before 16 Nov & receive a €10 discount: https://bit.ly/43o6YVY

ERJ Open Research: Patients who experienced CV events after COPD exacerbations received more intensive COPD treatment and had more HCRU compared with patients whose CV events occurred without COPD exacerbations in the prior 12 months https://bit.ly/4iuPxaW

🎙️ ERJ Podcast: Listen as Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in Isabella’s article in the most recent edition of the ERJ. Listen: https://channel.ersnet.org/channel-86-erj-podcast?contId=114954

ERJOR: Disease-modifying treatments in COPD are currently lacking. A novel platform for imaging inflammatory cytokine activity in airway disease may provide a new precision medicine approach to determine the most appropriate treatment for an individual. https://bit.ly/42BrJfH

ERJ Open Research: Alveolar macrophage carbon is increased in the distal airways of COPD patients compared to smokers with an inverse association with lung function. Presence of alveolar macrophage carbon alters cellular size and phenotype. https://bit.ly/43N5Zy8

“By participating we, as members, can shape the Society’s future” - Dr Ildikó Horváth, ERS Secretary General The deadline for applications and nominations for the ERS elections 2026 is 9 November! Apply or nominate a peer online: https://www.ersnet.org/the-society/elections-and-open-positions/

We have collated a selection of #ERSCongress 2025 sessions and made them free to view exclusively on the ERS Respiratory Channel 🎥 See what’s available: https://bit.ly/49CIjko Want more? You can still register and access all sessions until the end of the year!

ERJ Open Research: Alveolar macrophage carbon is increased in the distal airways of COPD patients compared to smokers with an inverse association with lung function. Presence of alveolar macrophage carbon alters cellular size and phenotype. https://bit.ly/43N5Zy8

The ERJ presents the latest in its series of podcasts. @donsin4 interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in ERJ. https://bit.ly/4hDovPT

ERJ Open Research: Iron-binding proteins and the microbiome in COPD https://bit.ly/4j0I4Bs

Ready to advance your career at the upcoming Respiratory Failure and Mechanical Ventilation (RFMV) Conference 2026? Read our Q&A with Dr Rebecca D'Cruz to learn what #RFMV2026 has to offer 👉 https://bit.ly/4oCcIDG #respiratory #respiratoryfailure #research #lunghealth #medicine

Compared to noninvasive risk stratification, haemodynamics is less age-dependent, has added prognostic value in patients aged <44 years and can be a valid treatment goal in patients with PAH aged >65 years not reaching a low-risk noninvasive assessment https://bit.ly/42Y1OAn

⚠️ #LSC2026: Abstract submission extended! You now have one more week to submit your abstract for presentation at the 24th ERS Lung Science Conference (19–22 March, 2026 in Estoril, Portugal and online). Submit before 23:59 CET on 10 November: channel.ersnet.org/hp-132-1-abs...

November is #Alpha1AwarenessMonth 🌍 Alpha-1 antitrypsin deficiency is a genetic condition causing damage to the lungs and/or liver. There is no cure, but some symptoms can be managed with treatment. Read more about the latest research on this condition: https://bit.ly/3X71QC4

ERJ Open Research: Population-based studies are needed to understand better the predictors of decline in mild–moderate COPD to develop suitable clinical tools for a “reach-out early” strategy to support better those susceptible to declining rapidly https://bit.ly/3DEevq6

🌍 This week, ERS has joined crucial discussions on the future of health in Europe at @who.int #RC75CPH in Copenhagen, Denmark. ERS Advocacy Council Chair Elect Prof. Zorana J. Andersen talks through the key takeaways from this week’s event for respiratory health.

ERJ Open Research: The genetic disease α1-antitrypsin deficiency is associated with 2–3-fold increased risks of atrial fibrillation hospitalisation, digoxin use and atrial fibrillation-related mortality https://bit.ly/4iMfi7K

🌍 On the final day of @who.int's #RC75CPH, ERS strongly supports a focus on childhood & adolescent health – led by Advocacy Council Chair Elect Prof. Zorana J. Andersen, who today emphasised the clear threats to children’s health posed by environmental degradation & climate change.

ERJ Open Research: Comorbidities in COPD group into profiles, identifying clusters of patients with varying disease burdens. These findings support more patient-centred strategies to potentially improve disease management. https://bit.ly/4iIkkle

🎙️ The latest ERS Monograph podcast on the “Pulmonary Hypertension” issue is now available! The episode explores diagnosis for non-specialists, the importance of the multidisciplinary team, and key areas for future research 💡 Listen now: https://bit.ly/47h1M8Y

🎥 We are at @who.int #RC75CPH this week, led by Prof. Zorana J. Andersen of the ERS Advocacy Council. As rising disinformation and the weakening of health & science programmes put evidence-based health decisions at risk, ERS & @europeanlung.bsky.social urge action: www.ersnet.org/news-and-fea...

ERJ Open Research: This large, nationwide cohort study highlights the potential risk of asthma attacks with use of progestogen-only contraceptive pills in younger women with eosinophilic asthma and low use of corticosteroids https://bit.ly/42FiOKp

🎥 Replays are now available for the special edition of ERS Vision Live: #ERSCongress highlights 2025. Access the replay of the full event, plus replays of each topic segment: channel.ersnet.org/channel-32-e...

Just a few days remaining to submit your abstract for #LSC2026! Do not miss this opportunity to present and discuss your research with your peers and worldwide experts in Estoril, Portugal – 19–22 March, 2026. Submit online: https://channel.ersnet.org/hp-132-1-abstracts-and-bursaries

Cardiovascular risk assessment in chronic respiratory disease is inconsistent. This review identifies existing methods, their strengths and limitations, and highlights the need for validated, tailored approaches to improve risk prediction and patient care. https://bit.ly/42osmda

ERJOR: Engagement with the current models of antenatal asthma care is suboptimal. A novel virtual model of antenatal asthma care significantly improved engagement compared to a face-to-face model and both models of care demonstrated clinical effectiveness. https://bit.ly/4iBWsjA

📹 Guidelines in Focus: Prof. Sanja Stanojevic interviews Prof. Amjad Horani about the newly published ERS and American Thoracic Society (ATS) clinical practice guidelines for the diagnosis of primary ciliary dyskinesia. Watch now: https://bit.ly/4nsyzfP

European Respiratory Review: Substantial variability exists in the prevalence and correlates of breathlessness, emphasising its complexity and multifaceted nature. https://bit.ly/465SBpZ

ERR: Post-tuberculosis morbidities and mortality are significant challenges. Developing host-directed therapies, implementing pulmonary rehabilitation and adopting well-tailored preventive strategies and screening protocols may be the potential solutions. https://bit.ly/4mgturk

🚨 #LSC2026: abstract submission closes this week! Why should you submit an abstract for the ERS Lung Science Conference 2026? Read insight from Dr Antonella Dost, award winner at #LSC2025: https://www.ersnet.org/news-and-features/news/the-ers-lung-science-conference-2026-submit-your-science/

#RFMV2026 is a not-to-be-missed event for pulmonologists, paediatricians, intensivists, and other professionals working in critical care. 📆 12–14 February, 2026 🌍 Rotterdam, Netherlands 💻 In-person and online Register your place: https://bit.ly/4iAt5xa

ERJOR: This systematic review and meta-analysis showed that patients who survive a hospital admission with COVID-19 remain at longer-term risk of hospital readmission with a frequency of 12% (95% CI 9–16%) and/or death with a frequency of 5% (95% CI 4–6%) https://bit.ly/41fyi6U

ERJ Open Research: Pneumonia risk scores lack precision in transplant recipients with CAP. Pneumonia scores should not be applied uncritically in this patient population and clinical expertise should take clear priority. https://bit.ly/4bx4jwf

ERJOR: Peripheral ED is frequent in patients with IPF. It is correlated with dyspnoea and functional variables, and worsens rapidly over time. Results highlight the links between the pulmonary compartment and the peripheral vascular compartment in IPF. https://bit.ly/4c0R4Eh

🎥 The ERS statement on advanced telemedicine for obstructive sleep apnoea - in brief! Statement co-chair Prof. Johan Verbraecken explains the key considerations made by the authors of this recently-published document 👇 Access the statement here: channel.ersnet.org/media-114698...

📋 ERS welcomes the inclusion of lung cancer as an officially recommended screening programme in the 5th update of the European Code Against Cancer, published this week. Read more online, including reaction from ERS President Prof. Joanna Chorostowska-Wynimko: www.ersnet.org/news-and-fea...

European Respiratory Journal: Genetic variants at the 17q12–q21 locus can interact with environmental pollutants to contribute to asthma pathogenesis https://bit.ly/40pWjsn

ERJ Open Research: Using SGRQ activity scores instead of the 6MWD, the mBODE index showed a stronger predictive performance with exacerbations than the BODE index, and both predict mortality in COPD https://bit.ly/3DBhOyq

Eur Respir J: There are two issues with using existing data from general-population biobanks to study PAH: low power and non-random misclassification. Relative to gold standard data, this results in false-positive and false-negative findings. https://bit.ly/4nksm6c

ERJ: This review highlights the influence of natural disasters on respiratory health in general populations and first-responders. It also calls for effective prevention and intervention strategies for protecting respiratory health during natural disasters. https://bit.ly/4f6Rcn9

Lymphocyte and granulocyte TL <10th percentile is common among TBD phenotype screen-positive patients undergoing transplant evaluation. Early greying has the highest sensitivity for TBD. Specificity increases with number of positive screening questions. https://bit.ly/4fO39wW

📖 The forthcoming ERS Monograph on “Chronic Cough” is now available to pre-order. The book will cover pathophysiology, assessment, management, treatable traits & future directions. Pre-order before 16 Nov & receive a €10 discount: https://bit.ly/43o6YVY

European Respiratory Journal: The monoclonal antibody cepeprubart reduced airway neutrophil and eosinophil numbers in COPD patients, suggesting therapeutic potential https://bit.ly/41zyE9A

The #Respiratory Failure and Mechanical Ventilation Conference 2026 offers cutting-edge scientific sessions and interactive educational content. 📆 12–14 February, 2026 🌍 Rotterdam, Netherlands 💻 In-person and online Register your place: https://bit.ly/4iAt5xa #RFMV2026